Last month MMV co-hosted a meeting for donors in Barcelona on the importance of partnerships in the fight against malaria, and took this opportunity to interview experts in this field on the need for sustainable financing.
In 2008-09, $1.6 billion was committed to malaria control – almost 6 times what was committed in 2003. Why has this not been enough to defeat malaria?
Dr Dennis Schmatz
President and CEO
Medicines for Malaria Venture; President, MMV North America, Inc. Board; Former Vice President, Head of Tsukuba Research Institute, Merck Research Laboratories
Dr Pedro Alonso
Director and Professor
Barcelona Center for International Health Research (CRESIB) Hospital Clinic Universitat de Barcelona; MMV Board Member
Dr Awa Marie Coll-Seck
Roll Back Malaria Partnership; MMV Board Observer